SNT 10.6% 5.2¢ syntara limited

PXS orbital inhaler trial for tuberculosis, page-2

  1. 272 Posts.
    Bakkie, the reason is because it seems this company is a dead duck!!!! Not sure why i dont sell. I am holding on with hope it can somehow recover (Heart) however there is not doubt i should be using my head and just moving on. This is like someone pressing needles in your eyes. A slow and painful death!!! Share is just slowly drifting into oblivion!!!

    Regards

    Ace
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.